No Data
No Data
10-Q: Quarterly report
News On AgeX Therapeutics Inc. (AGE) Now Under SER
News On AgeX Therapeutics Inc. (AGE) Now Under SER
Serina Therapeutics Announces Completion of Merger With AgeX Therapeutics
Shares of Serina to commence trading on NYSE American under the ticker symbol "SER" on March 27, 2024Lead candidate SER-252, POZ-apomorphine preclinical studies anticipated to be completed in the fourth quarter of 2024;
AgeX Therapeutics GAAP EPS of -$13.73
AgeX Therapeutics Secures Funding, Details in SEC Report
AgeX Therapeutics Postpones Merger Completion With Serina
No Data